MoonLake Immunotherapeutics (MLTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for MoonLake Immunotherapeutics, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$12.31
+3.19% today
Market cap
$1.0B
Overall quality
—
Kronos AI 30-day
+19.4%
8 of 8 simulated paths end higher
MoonLake Immunotherapeutics (MLTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.0B. It trades at $12.31, up 3.19% today. 8 analysts' average target of $33.00 implies +168.1% from today's price. Kronos AI's 30-day forecast is +19.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $33.00 |
| Low – high | $17.00 – $50.00 |
| Analysts | 8 |
| Upside to average | +168.1% |
Kronos AI 30-day forecast
| Expected close | $14.25 (+19.4%) |
| Likely range | +14.8% … +31.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.